Evidence map›Paper›PMID 41939689›Full record

ArticleCureus2026

Beyond Iron Deficiency: An Atypical Peripheral Smear Revealing Hemoglobin C in an Adolescent.

Mahmoud Hamidine, Mehdi Awati, Aziki Mehdi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahmoud HamidineDepartment of Hematology and Oncology, Avicenna Hospital, Medical School of Cadi Ayyad University, Marrakech, MAR.
Mehdi AwatiDepartment of Biological Hematology, Avicenna Hospital, Medical School of Cadi Ayyad University, Marrakech, MAR.
Aziki MehdiDepartment of Biological Hematology, Avicenna Hospital, Marrakech, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemoglobinopathies are among the most common inherited disorders worldwide and represent a significant public health concern. The clinical presentation varies depending on genetic status--heterozygous or homozygous--and may involve structural abnormalities, defects in hemoglobin synthesis, or both. Despite their prevalence, hemoglobinopathies remain underdiagnosed, particularly when masked by more common causes of anemia. We report a 14-year-old male adolescent with no significant past medical history, referred for evaluation of microcytic hypochromic anemia. The clinical examination revealed pallor and mild splenomegaly, while laboratory tests showed low serum ferritin, decreased folate levels, and mild hyperbilirubinemia. Peripheral blood smear demonstrated target cells, anulocytes, dacryocytes, and occasional crystal-like erythrocytes. Hemoglobin electrophoresis and high-performance liquid chromatography (HPLC) confirmed a heterozygous hemoglobin C (HbC), previously unrecognized in the patient and his family. This case highlights the importance of considering hemoglobinopathies in the differential diagnosis of microcytic hypochromic anemia, even when iron deficiency appears to be the most likely cause. It emphasizes the diagnostic value of peripheral blood smear, an investigation often overlooked in routine practice, which was crucial for identifying heterozygous HbC in this patient. Beyond the individual case, it underscores the need for systematic diagnostic approaches, genetic counseling, and family screening to reduce underdiagnosis and mitigate the public health impact of hemoglobinopathies.

Indexed as

anemiahemoglobin chemoglobinopathyiron deficiencyperipheral blood smear

Identifiers

PMID41939689
PMCPMC13050268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.